Language: Spanish
References: 11
Page: 272-273
PDF size: 159.48 Kb.

Text Extraction

No abstract.

REFERENCES

1. Parsons, J., “Transient acantholytic dermatosis (Grover’s disease): a global perspective”, J Am Acad Dermatol, 1996, 35: 653-666.

2. Weaver, J. y Bergfeld, W.F., “Grover disease (transient acantholytic dermatosis)”, Arch Pathol Lab Med, 2009, 133: 1490-1494.

3. Quirk, C. y Heenan, P., “Grover’s disease: 34 years on”, Australasian J Dermatol, 2004, 45: 83-88.

4. Fernández-Figueras, M.T., Puig, L., Cannata, P. et al., “Grover disease: a reappraisal of histopathological diagnostic criteria in 120 cases”, Am J Dermatopathol, 2010, 32: 541-549.

5. Davies, M.D.P., Dinneen, A.M., Landa, N. y Gibson, L., “Grover’s disease: clinicopathologic review of 72 cases”, Mayo Clinic Proceedings, 1999, 74: 229-234.

6. Scheinfeld, N. y Mones, J., “Seasonal variation of transient acantholytic dyskeratosis (Grover’s disease)”, J Am Acad Dermatol, 2006, 6: 263-268.

7. Phillips, C., Kalantari-Dehaghi, M., Marchenko, S., Chernyavsky, A.I., Galitovskiy, V., Gindi, V. et al., “Is Grover’s disease an autoimmune dermatosis?”, Experimental Dermatology, 2013, 22, 781-784.

8. Powell, J., Sakuntabhai, A., James, M. et al., “Grover’s disease, despite histological similarity to Darier’s disease, does not share an abnormality in the atp2a2 gene”, Br J Dermatol, 2000, 143: 658.

9. Simon, R.S., Bloom, D., Ackerman, A.B., “Persistent acantholytic dermatosis”, Arch Dermatol, 1976, 112: 1429-1431.

10. Khan, M. y Berth-Jones, J., “Transient acantholytic dermatosis (Grover disease)”, en Lebwohl, M.G., Heymann, W.R., Berth-Jones, J. y Coulson, I., Treatment of skin disease: a comprehensive therapeutic strategies, 4ª ed., Londres, Elsevier Saunders, 2014: 770-772.

11. Norman, R., “Use of etanercept in treating pruritus and preventing new lesions in Grover disease”, J Am Acad Dermatol, 2011, 64: 796-798.